H. Golding

发表

A Potent Germline-like Human Monoclonal Antibody Targets a pH-Sensitive Epitope on H7N9 Influenza Hemagglutinin

Wei Li, D. Dimitrov, X. Ji, 2017, Cell Host & Microbe.

Influenza A Virus Hemagglutinin Trimerization Completes 1 Monomer Folding and Antigenicity 2 3

Javier G. Magadán, Gregory M. Frank, J. Yewdell, 2013 .

Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin

Surender Khurana, Hana Golding, Hua-Xin Liao, 2011, Proceedings of the National Academy of Sciences.

Antibody-dependent enhancement of influenza disease promoted by increase in hemagglutinin stem flexibility and virus fusion kinetics

H. Turner, A. Ward, S. Khurana, 2019, Proceedings of the National Academy of Sciences.

Preconfiguration of the antigen-binding site during affinity maturation of a broadly neutralizing influenza virus antibody

Thomas B. Kepler, Huafeng Xu, Surender Khurana, 2012, Proceedings of the National Academy of Sciences.

Immunoglobulin G3 from Polyclonal Human Immunodeficiency Virus (HIV) Immune Globulin Is More Potent than Other Subclasses in Neutralizing HIV Type 1

D. Scott, B. Golding, L. King, 2001, Journal of Virology.

Human peripheral blood CD4+ and CD8+ T cells express Th1-like cytokine mRNA and proteins following in vitro stimulation with heat-inactivated Brucella abortus

M. Betts, A. Yamauchi, B. Golding, 1995, Infection and immunity.

Brucella abortus conjugated with a gp120 or V3 loop peptide derived from human immunodeficiency virus (HIV) type 1 induces neutralizing anti-HIV antibodies, and the V3-B. abortus conjugate is effective even after CD4+ T-cell depletion

N. Blyveis, B. Golding, J. Inman, 1995, Journal of virology.

Retroviruses and Their Roles in Chronic Inflammatory Diseases and Autoimmunity

R. Garry, R. Montelaro, H. Golding, 1995 .

H5 N-terminal β sheet promotes oligomerization of H7-HA1 that induces better antibody affinity maturation and enhanced protection against H7N7 and H7N9 viruses compared to inactivated influenza vaccine.

S. Khurana, J. Manischewitz, L. King, 2014, Vaccine.

Common epitope in human immunodeficiency virus (HIV) I-GP41 and HLA class II elicits immunosuppressive autoantibodies capable of contributing to immune dysfunction in HIV I-infected individuals.

M. Clerici, B. Golding, G. Shearer, 1989, The Journal of clinical investigation.

Production of fever mediator PGE2 in human monocytes activated with MDP adjuvant is controlled by signaling from MAPK and p300 HAT: Key role of T cell derived factor.

Yun-Jong Park, H. Golding, M. Zaitseva, 2020, Molecular immunology.

Smallpox vaccine–induced antibodies are necessary and sufficient for protection against monkeypox virus

K. Reimann, M. Bray, D. Scott, 2005, Nature Medicine.

Live attenuated influenza A virus vaccine protects against A(H1N1)pdm09 heterologous challenge without vaccine associated enhanced respiratory disease.

A. Vincent, P. Gauger, D. Pérez, 2014, Virology.

Up‐regulation of HIV coreceptor CXCR4 expression in human T lymphocytes is mediated in part by a cAMP‐responsive element

D. Dimitrov, R. Dewar, B. Bierer, 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

The phorbol ester phorbol myristate acetate inhibits human immunodeficiency virus type 1 envelope-mediated fusion by modulating an accessory component(s) in CD4-expressing cells

D. Dimitrov, R. Blumenthal, J. Manischewitz, 1994, Journal of virology.

Production of recombinant proteins by vaccinia virus in a microcarrier based mammalian cell perfusion bioreactor.

W. Bentley, J. Shiloach, H. Golding, 2005, Biotechnology and bioengineering.

Conversion of MDCK cell line to suspension culture by transfecting with human siat7e gene and its application for influenza virus production

J. Shiloach, M. Betenbaugh, H. Golding, 2009, Proceedings of the National Academy of Sciences.

Influenza A Virus Hemagglutinin Trimerization Completes

Javier G. Magadán, Gregory M. Frank, J. Yewdell, 2013 .

from lethality by reducing viral loads in the upper respiratory tract and internal organs. 2

Senta M Kapnick, J. Manischewitz, L. King, 2011 .

Passive Immunotherapies Protect WRvFire and IHD-J-Luc Vaccinia Virus-Infected Mice from Lethality by Reducing Viral Loads in the Upper Respiratory Tract and Internal Organs

Senta M Kapnick, J. Manischewitz, L. King, 2011, Journal of Virology.

RESEARCH Open Access

Shengwang Liu, Senta M Kapnick, M. Mikolajczyk, 1996 .

Smallpox vaccine does not protect macaques with AIDS from a lethal monkeypox virus challenge.

D. Venzon, Mark G. Lewis, M. Bray, 2005, The Journal of infectious diseases.

HIV coreceptors: role of structure, posttranslational modifications, and internalization in viral-cell fusion and as targets for entry inhibitors.

K. Peden, H. Golding, M. Zaitseva, 2003, Biochimica et biophysica acta.

Autoreactivity of Broadly Neutralizing Influenza Human Antibodies to Human Tissues and Human Proteins

S. Khurana, H. Golding, Laura Klenow, 2020, Viruses.

Broad Hemagglutinin-Specific Memory B Cell Expansion by Seasonal Influenza Virus Infection Reflects Early-Life Imprinting and Adaptation to the Infecting Virus

Francisco A. Chaves, R. Ahmed, Hongmei Yang, 2019, Journal of Virology.

Recombinant HA1 produced in E. coli forms functional oligomers and generates strain-specific SRID potency antibodies for pandemic influenza vaccines.

A. Steven, J. Fontana, C. Larkin, 2011, Vaccine.

Vaccines with MF59 Adjuvant Expand the Antibody Repertoire to Target Protective Sites of Pandemic Avian H5N1 Influenza Virus

R. Rappuoli, M. Rock, K. Edwards, 2010, Science Translational Medicine.

Induction of HIV-1 IIIb neutralizing antibodies in BALB/c mice by a chimaeric peptide consisting of a T-helper cell epitope of Semliki Forest virus and a B-cell epitope of HIV.

R. Meloen, B. Golding, H. Golding, 1998, Vaccine.

Differential human antibody repertoires following Zika infection and the implications for serodiagnostics and disease outcome

S. Khurana, H. Golding, G. Ruiz-Palacios, 2019, Nature Communications.

Oligomeric Recombinant H5 HA1 Vaccine Produced in Bacteria Protects Ferrets from Homologous and Heterologous Wild-Type H5N1 Influenza Challenge and Controls Viral Loads Better than Subunit H5N1 Vaccine by Eliciting High-Affinity Antibodies

J. Fontana, S. Khurana, H. Golding, 2012, Journal of Virology.

H5N1-SeroDetect EIA and Rapid Test: a Novel Differential Diagnostic Assay for Serodiagnosis of H5N1 Infections and Surveillance

P. Horby, N. T. Hien, N. Liem, 2011, Journal of Virology.

Repeat vaccination reduces antibody affinity maturation across different influenza vaccine platforms in humans

J. Treanor, S. Khurana, L. King, 2019, Nature Communications.

What Is the Predictive Value of Animal Models for Vaccine Efficacy in Humans? The Importance of Bridging Studies and Species-Independent Correlates of Protection.

S. Khurana, H. Golding, M. Zaitseva, 2018, Cold Spring Harbor perspectives in biology.

Preexisting Immunity, Not Frailty Phenotype, Predicts Influenza Postvaccination Titers among Older Veterans

T. Tumpey, H. Golding, M. Pearce, 2017, Clinical and Vaccine Immunology.

Potential use of inflammation and early immunological event biomarkers in assessing vaccine safety.

P. Lambert, H. Golding, I. Gust, 2013, Biologicals : journal of the International Association of Biological Standardization.

Strategies for the Stimulation of Th Cell Subsets

B. Golding, H. Golding, M. Zaitseva, 1995 .

DNA priming prior to inactivated influenza A(H5N1) vaccination expands the antibody epitope repertoire and increases affinity maturation in a boost-interval-dependent manner in adults.

B. Graham, J. Ledgerwood, S. Khurana, 2013, The Journal of infectious diseases.

High-Af fi nity H 7 Head and Stalk Domain – Speci fi c Antibody Responses to an Inactivated In fl uenza H 7 N 7 Vaccine After Priming With Live Attenuated In fl uenza Vaccine

Steven F. Baker, K. Subbarao, Hongmei Yang, 2015 .

Oral Priming with Replicating Adenovirus Serotype 4 Followed by Subunit H5N1 Vaccine Boost Promotes Antibody Affinity Maturation and Expands H5N1 Cross-Clade Neutralization

S. Khurana, J. Manischewitz, L. King, 2015, PloS one.

ISCOMATRIX™ adjuvant promotes epitope spreading and antibody affinity maturation of influenza A H7N9 virus like particle vaccine that correlate with virus neutralization in humans.

G. Glenn, S. Khurana, L. King, 2015, Vaccine.

High-Affinity H7 Head and Stalk Domain-Specific Antibody Responses to an Inactivated Influenza H7N7 Vaccine After Priming With Live Attenuated Influenza Vaccine.

Steven F. Baker, K. Subbarao, Hongmei Yang, 2015, The Journal of infectious diseases.

Heterologous Prime-Boost Vaccination with MF59-Adjuvanted H5 Vaccines Promotes Antibody Affinity Maturation towards the Hemagglutinin HA1 Domain and Broad H5N1 Cross-Clade Neutralization

S. Khurana, H. Golding, Elizabeth M. Coyle, 2014, PloS one.

A live attenuated influenza A(H5N1) vaccine induces long-term immunity in the absence of a primary antibody response.

R. Karron, D. Follmann, K. Subbarao, 2014, The Journal of infectious diseases.

Antigenic Fingerprinting of H5N1 Avian Influenza Using Convalescent Sera and Monoclonal Antibodies Reveals Potential Vaccine and Diagnostic Targets

K. Subbarao, F. Sallusto, A. Lanzavecchia, 2009, PLoS medicine.

Properly Folded Bacterially Expressed H1N1 Hemagglutinin Globular Head and Ectodomain Vaccines Protect Ferrets against H1N1 Pandemic Influenza Virus

S. Khurana, J. Manischewitz, L. King, 2010, PloS one.

MF59 Adjuvant Enhances Diversity and Affinity of Antibody-Mediated Immune Response to Pandemic Influenza Vaccines

J. Yewdell, R. Rappuoli, S. Khurana, 2011, Science Translational Medicine.

Antigenic fingerprinting of RSV-A infected hematopoietic cell transplant recipients reveals importance of mucosal anti-RSV-G antibodies in control of RSV infection in humans.

S. Khurana, H. Golding, P. Piedra, 2019, The Journal of infectious diseases.

Development of bioluminescence imaging of respiratory syncytial virus (RSV) in virus-infected live mice and its use for evaluation of therapeutics and vaccines.

S. Khurana, H. Golding, Sandra M. Fuentes, 2017, Vaccine.

Antigenic Fingerprinting following Primary RSV Infection in Young Children Identifies Novel Antigenic Sites and Reveals Unlinked Evolution of Human Antibody Repertoires to Fusion and Attachment Glycoproteins

S. Khurana, H. Golding, Elizabeth M. Coyle, 2016, PLoS pathogens.

Novel antibody-independent receptor-binding SPR-based assay for rapid measurement of influenza vaccine potency.

S. Khurana, J. Manischewitz, L. King, 2014, Vaccine.

Evidence for Cell-Surface Association Between Fusin and the CD4-gp120 Complex in Human Cell Lines

D. Dimitrov, H. Golding, N. Nguyen, 1996, Science.

Immunologic mechanisms of seasonal influenza vaccination administered by microneedle patch from a randomized phase I trial

S. Henry, D. McAllister, M. Prausnitz, 2021, NPJ vaccines.

Durable neutralizing antibodies after remote smallpox vaccination among adults with and without HIV infection

J. Manischewitz, L. King, H. Golding, 2007, AIDS.

Global Analyses of Human Immune Variation Reveal Baseline Predictors of Postvaccination Responses

J. P. McCoy, F. Marincola, Manikandan Narayanan, 2014, Cell.

Characterization of antigen-specific, Ia-restricted, L3T4+ cytolytic T lymphocytes and assessment of thymic influence on their self specificity

A. Singer, H. Golding, T. Munitz, 1985, The Journal of experimental medicine.

Co-ligation of alpha4beta1 integrin and TCR rescues human thymocytes from steroid-induced apoptosis.

E. Shevach, H. Golding, D. Salomon, 1998, International immunology.

Co-ligation of α 4 β 1 integrin and TCR rescues human thymocytes from steroid-induced apoptosis

E. Shevach, H. Golding, D. Salomon, 1998 .

Cytokines regulate expression and function of the HIV coreceptor CXCR4 on human mature dendritic cells.

A. Blauvelt, H. Golding, H. Mostowski, 1998, Journal of immunology.

Re-evaluation of the involvement of the adhesion molecules ICAM-1/LFA-1 in syncytia formation of HIV-1-infected subclones of a CEM T-cell leukemic line.

D. S. Webb, H. Golding, H. Mostowski, 1991, AIDS research and human retroviruses.

Kinetics of soluble CD4 binding to cells expressing human immunodeficiency virus type 1 envelope glycoprotein

D. Dimitrov, R. Blumenthal, J. Manischewitz, 1992, Journal of virology.

Human Immunodeficiency Virus (HIV) Vaccine Trials: a Novel Assay for Differential Diagnosis of HIV Infections in the Face of Vaccine-Generated Antibodies

Jerome H. Kim, D. Cooper, R. Bailer, 2006, Journal of Virology.

A systematic review and meta-analysis of cross-reactivity of antibodies induced by oil-in-water emulsion adjuvanted influenza H5N1 virus monovalent vaccines.

S. Anderson, R. Forshee, H. Golding, 2017, Vaccine.

CD4-derived synthetic peptide blocks the binding of HIV-1 GP120 to CD4-bearing cells and prevents HIV-1 infection.

H. Golding, F. Robey, L. Vujcic, 1990, Cellular immunology.

CCR8 on Human Thymocytes Functions as a Human Immunodeficiency Virus Type 1 Coreceptor

L. King, H. Golding, P. Murphy, 2000, Journal of Virology.

Development of a novel vaccinia-neutralization assay based on reporter-gene expression.

T. Monath, J. Shiloach, D. Scott, 2003, The Journal of infectious diseases.

Human immunodeficiency virus type 1 infection of mature CD3hiCD8+ thymocytes

M. Baseler, J. Adelsberger, H. Golding, 1997, Journal of virology.

Safety and immunogenicity of UBI HIV-1MN octameric V3 peptide vaccine administered by subcutaneous injection.

D. Cooper, C. Duncombe, A. Kelleher, 1997, AIDS research and human retroviruses.

Specificity, phenotype, and precursor frequency of primary cytolytic T lymphocytes specific for class II major histocompatibility antigens.

A. Singer, H. Golding, 1985, Journal of immunology.

Preclinical evaluation of bacterially produced RSV-G protein vaccine: Strong protection against RSV challenge in cotton rat model

S. Khurana, H. Golding, Laura Klenow, 2017, Scientific Reports.

H5N1 Virus-Like Particle Vaccine Elicits Cross-Reactive Neutralizing Antibodies That Preferentially Bind to the Oligomeric Form of Influenza Virus Hemagglutinin in Humans

G. Glenn, S. Khurana, J. Manischewitz, 2011, Journal of Virology.

A Rapid Flp-In System for Expression of Secreted H5N1 Influenza Hemagglutinin Vaccine Immunogen in Mammalian Cells

S. Khurana, J. Manischewitz, L. King, 2011, PloS one.

on Human Mature Dendritic Cells and Function of the HIV Coreceptor CXCR4 Cutting Edge: Cytokines Regulate Expression

A. Blauvelt, H. Golding, H. Mostowski, 1998 .

Human Peripheral Blood T Cells, Monocytes, and Macrophages Secrete Macrophage Inflammatory Proteins 1α and 1β following Stimulation with Heat-Inactivated Brucella abortus

B. Golding, J. Manischewitz, L. King, 2001, Infection and Immunity.

Interferong and interleukin 6 modulate the susceptibility of macrophages to human immunodeficiency virus type 1 infection

J. Manischewitz, L. King, H. Golding, 2000 .

Role in HIV-1 Infection Thymocytes: Biological Function and CXCR4 and CCR5 on Human

R. Rabin, K. Peden, H. Golding, 2010 .

Infection Biological Function and Role in HIV-1 CXCR 4 and CCR 5 on Human Thymocytes : Murphy and

Tiffany, R. Rabin, K. Peden, 1998 .

Clinical and immunological comparison of smallpox vaccine administered to the outer versus the inner upper arms of vaccinia-naive adults.

R. Topolski, J. Manischewitz, L. King, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The potential for recruiting immune responses toward type 1 or type 2 T cell help.

B. Golding, H. Golding, M. Zaitseva, 1994, The American journal of tropical medicine and hygiene.

Epitope diversity of SARS-CoV-2 hyperimmune intravenous human immunoglobulins and neutralization of variants of concern

B. Golding, S. Khurana, H. Golding, 2021, iScience.

Reduced neutralization of SARS-CoV-2 variants by convalescent plasma and hyperimmune intravenous immunoglobulins for treatment of COVID-19

B. Golding, S. Khurana, H. Golding, 2021, bioRxiv.

Antigenic Fingerprinting of Respiratory Syncytial Virus (RSV)-A–Infected Hematopoietic Cell Transplant Recipients Reveals Importance of Mucosal Anti–RSV G Antibodies in Control of RSV Infection in Humans

S. Khurana, H. Golding, Megan A. Hahn, 2020 .

Antigenic Fingerprinting of Antibody Response in Humans following Exposure to Highly Pathogenic H7N7 Avian Influenza Virus: Evidence for Anti-PA-X Antibodies

S. Khurana, H. Golding, A. Meijer, 2016, Journal of Virology.

Novel Approach for Differential Diagnosis of HIV Infections in the Face of Vaccine-Generated Antibodies: Utility for Detection of Diverse HIV-1 Subtypes

M. Altfeld, S. Zolla-Pazner, A. Kamali, 2006, Journal of acquired immune deficiency syndromes.

Immune Response to SARS-CoV-2 Vaccine and Following Breakthrough Omicron Infection in an Autoimmune Patient with Hashimoto’s Thyroiditis, Pernicious Anemia, and Chronic Atrophic Autoimmune Gastritis: A Case Report

S. Khurana, H. Golding, Lorenza Bellusci, 2022, Vaccines.

Neutralisation of circulating SARS-CoV-2 delta and omicron variants by convalescent plasma and SARS-CoV-2 hyperimmune intravenous human immunoglobulins for treatment of COVID-19

S. Khurana, H. Golding, Lorenza Bellusci, 2022, Annals of the Rheumatic Diseases.

Statistical Approach To Estimate Vaccinia-Speciﬁc Neutralizing Antibody Titers Using a High-Throughput Assay (cid:1)

V. Pankratz, R. Kennedy, G. Poland, 2009 .

Effects of Postchallenge Administration of ST-246 on Dissemination of IHD-J-Luc Vaccinia Virus in Normal Mice and in Immune-Deficient Mice Reconstituted with T Cells

R. Jordan, J. Manischewitz, L. King, 2013, Journal of Virology.

Intravenous immunoglobulin products contain neutralizing antibodies to vaccinia

D. Scott, M. Mikolajczyk, J. Manischewitz, 2004, Vox sanguinis.

Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model.

A. Mayer, J. Manischewitz, L. King, 2005, Virology.

T-cell recognition of a chimaeric class II/class I MHC molecule and the role of L3T4

R. Germain, D. Margulies, A. Singer, 1985, Nature.

A practical influenza neutralization assay to simultaneously quantify hemagglutinin and neuraminidase-inhibiting antibody responses.

M. Eichelberger, J. Manischewitz, L. King, 2010, Vaccine.

CXCR4 heterogeneity in primary cells: possible role of ubiquitination

E. Petricoin, J. Manischewitz, L. King, 2002, Journal of leukocyte biology.

Fusion of monocytes and macrophages with HIV-1 correlates with biochemical properties of CXCR4 and CCR5

H. Golding, M. Zaitseva, C. Lapham, 1999, Nature Medicine.

Enhancement of human immunodeficiency virus type 1 envelope-mediated fusion by a CD4-gp120 complex-specific monoclonal antibody

C. Broder, D. Dimitrov, J. Gershoni, 1997, Journal of virology.

Structural Determinants of the Anti-HIV Activity of a CCR5 Antagonist Derived from Toxoplasma gondii*

J. Andersen, A. Sher, J. Aliberti, 2004, Journal of Biological Chemistry.

Inhibition of HIV-1 infection by a CCR5-binding cyclophilin from Toxoplasma gondii.

J. Andersen, A. Sher, J. Aliberti, 2003, Blood.

Both L3T4+ and Lyt-2+ helper T cells initiate cytotoxic T lymphocyte responses against allogenic major histocompatibility antigens but not against trinitrophenyl-modified self

L. Glimcher, A. Singer, T. Malek, 1985, The Journal of experimental medicine.

Increased CXCR4‐dependent HIV‐1 fusion in activated T cells: role of CD4/CXCR4 association

J. Manischewitz, H. Golding, M. Zaitseva, 2005 .

Common sequence in HIV 1 GP41 and HLA class II beta chains can generate crossreactive autoantibodies with immunosuppressive potential early in the course of HIV 1 infection.

J. Goedert, M. Clerici, B. Golding, 1991, Advances in experimental medicine and biology.

Brucella abortus as a potential vaccine candidate: induction of interleukin-12 secretion and enhanced B7.1 and B7.2 and intercellular adhesion molecule 1 surface expression in elutriated human monocytes stimulated by heat-inactivated B. abortus

B. Golding, J. Manischewitz, H. Golding, 1996, Infection and immunity.

heat-inactivated B . abortus . elutriated human monocytes stimulated by adhesion molecule 1 surface expression in and enhanced B 7 . 1 and B 7 . 2 and intercellular secretioncandidate : induction of interleukin-12 Brucella abortus as a potential vaccine

B. Golding, J. Manischewitz, H. Golding, 1996 .

Recognition Requirements for the Activation, Differentiation and Function of T‐Helper Cells Specific for Class I MHC Alloantigens

A. Singer, A. Rosenberg, H. Golding, 1987, Immunological reviews.

Study of viral replication in HIV-1-infected CEM T-cell subclones which are reduced in their ability to form syncytia.

I. Hewlett, J. Manischewitz, H. Golding, 1992, AIDS research and human retroviruses.

Immunity and protection against Brucella abortus.

D. Scott, B. Golding, H. Golding, 2001, Microbes and infection.

Impact of convalescent plasma therapy on SARS CoV-2 antibody profile in COVID-19 patients.

S. Khurana, H. Golding, Juanjie Tang, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Impact of Convalescent Plasma Therapy on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Profile in Coronavirus Disease 2019 (COVID-19) Patients

S. Khurana, H. Golding, Juanjie Tang, 2021, Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America.

Application of Bioluminescence Imaging to the Prediction of Lethality in Vaccinia Virus-Infected Mice

Senta M Kapnick, J. Manischewitz, L. King, 2009, Journal of Virology.

Antibodies to the A27 protein of vaccinia virus neutralize and protect against infection but represent a minor component of Dryvax vaccine--induced immunity.

I. Berkower, J. Manischewitz, H. Golding, 2007, The Journal of infectious diseases.

Subunit Recombinant Vaccine Protects against Monkeypox1

D. Venzon, J. Héraud, M. Bray, 2006, The Journal of Immunology.

Use of human MonoMac6 cells for development of in vitro assay predictive of adjuvant safety in vivo.

H. Golding, L. Sirota, M. Zaitseva, 2012, Vaccine.

Design of Vaccines for the Induction of Antibody Responses in Th-Cell Deficient Individuals

B. Golding, J. Inman, H. Golding, 1995 .

A polymer containing a repeating peptide sequence can stimulate T-cell-independent IgG antibody production in vivo.

H. Golding, Robert Blackburn, K. Hillman, 1991, Cellular immunology.

Antibody affinity maturation and cross-variant activity following SARS-CoV-2 mRNA vaccination: Impact of prior exposure and sex

S. Khurana, H. Golding, T. Ross, 2021, EBioMedicine.

Measurements of vaccinia virus dissemination using whole body imaging: approaches for predicting of lethality in challenge models and testing of vaccines and antiviral treatments.

Senta M Kapnick, H. Golding, M. Zaitseva, 2012, Methods in molecular biology.

Correlation between kinetics of soluble CD4 interactions with HIV‐1-Env‐expressing cells and inhibition of syncytia formation: implications for mechanisms of cell fusion and therapy for AIDS

D. Dimitrov, R. Blumenthal, J. Manischewitz, 1992, AIDS.

Kinetics ofSoluble CD4Binding toCells Expressing Human Immunodeficiency VirusType1Envelope Glycoprotein

R. Blumenthal, J. Manischewitz, H. Golding, 1992 .

Antibody affinity and cross-variant neutralization of SARS-CoV-2 Omicron BA.1, BA.2 and BA.3 following third mRNA vaccination

S. Khurana, H. Golding, T. Ross, 2022, Nature Communications.

Nonglycosylated G-Protein Vaccine Protects against Homologous and Heterologous Respiratory Syncytial Virus (RSV) Challenge, while Glycosylated G Enhances RSV Lung Pathology and Cytokine Levels

S. Khurana, H. Golding, Elizabeth M. Coyle, 2015, Journal of Virology.

Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses

Rachel L. Spreng, D. Weissman, C. Woods, 2021, Nature.

Antibiotics-Driven Gut Microbiome Perturbation Alters Immunity to Vaccines in Humans

B. Pulendran, Jishnu Das, G. Alter, 2019, Cell.

Breadth of SARS-CoV-2 Neutralization and Protection Induced by a Nanoparticle Vaccine

D. Weissman, Haiyan Chen, Laura L. Sutherland, 2022, bioRxiv.

A broadly cross-reactive antibody neutralizes and protects against sarbecovirus challenge in mice

R. J. Edwards, B. Haynes, J. Mascola, 2021, Science Translational Medicine.

Predictive markers of safety and immunogenicity of adjuvanted vaccines.

H. Golding, M. Gruber, N. Garçon, 2013, Biologicals : journal of the International Association of Biological Standardization.

D-dimer and CoV-2 spike-immune complexes contribute to the production of PGE2 and proinflammatory cytokines in monocytes

Yun-Jong Park, S. Khurana, H. Golding, 2022, PLoS pathogens.

Electroporation of Synthetic DNA Antigens Offers Protection in Nonhuman Primates Challenged with Highly Pathogenic Avian Influenza Virus

D. Weiner, Jian Yan, Mark G. Lewis, 2009, Journal of Virology.

Identification of a Linear Peptide Recognized by Monoclonal Antibody 2D7 Capable of Generating CCR5-Specific Antibodies with Human Immunodeficiency Virus-Neutralizing Activity

Surender Khurana, Hana Golding, S. Khurana, 2005, Journal of Virology.

CXCR4 and CCR5 on human thymocytes: biological function and role in HIV-1 infection.

R. Rabin, K. Peden, H. Golding, 1998, Journal of immunology.

Expression and function of CCR5 and CXCR4 on human Langerhans cells and macrophages: Implications for HIV primary infection

A. Blauvelt, J. Manischewitz, H. Golding, 1997, Nature Medicine.

Protective antigenic sites in respiratory syncytial virus G attachment protein outside the central conserved and cysteine noose domains

S. Khurana, H. Golding, Laura Klenow, 2018, PLoS pathogens.

Role of accessory cell processing and presentation of shed H-2 alloantigens in allospecific cytotoxic T lymphocyte responses.

A. Singer, H. Golding, 1984, Journal of immunology.

Antibody affinity maturation and plasma IgA associate with clinical outcome in hospitalized COVID-19 patients

S. Khurana, H. Golding, Juanjie Tang, 2021, Nature Communications.

Stromal-Derived Factor 1 Expression in the Human Thymus

Andrew Blauvelt, Hana Golding, Tatsuyoshi Kawamura, 2002, The Journal of Immunology.

Global Analyses of Human Immune Variation Reveal Baseline Predictors of Postvaccination Responses

Yuri Kotliarov, Wei Wang, Manikandan Narayanan, 2014, Cell.

Both L3T4+ and Lyt-2+ helper T cells initiate cytotoxic T lymphocyte responses against allogenic major histocompatibility antigens but not against trinitrophenyl-modified self

A. Singer, T. Malek, A. Rosenberg, 1985, The Journal of experimental medicine.

Development of an animal model of progressive vaccinia in nu/nu mice and the use of bioluminescence imaging for assessment of the efficacy of monoclonal antibodies against vaccinial B5 and L1 proteins

Y. Xiang, S. Crotty, H. Golding, 2017, Antiviral research.

Antibody signature induced by SARS-CoV-2 spike protein immunogens in rabbits

S. Khurana, H. Golding, Juanjie Tang, 2020, Science Translational Medicine.

Development of a simple, rapid, sensitive, high-throughput luciferase reporter based microneutralization test for measurement of virus neutralizing antibodies following Respiratory Syncytial Virus vaccination and infection.

S. Khurana, H. Golding, M. Teng, 2013, Vaccine.

Postchallenge Administration of Brincidofovir Protects Healthy and Immune-Deficient Mice Reconstituted with Limited Numbers of T Cells from Lethal Challenge with IHD-J-Luc Vaccinia Virus

H. Golding, M. Zaitseva, L. Trost, 2015, Journal of Virology.

eview IV vaccine-induced sero-reactivity : A challenge for trial participants , esearchers , and physicians ISR Working Group of the Global HIV Vaccine Enterprise

H. Golding, Yegor Voronina, M. Allenf, 2015 .

Production of Potent Fully Human Polyclonal Antibodies against Ebola Zaire Virus in Transchromosomal Cattle

J. Dye, A. Herbert, A. Kuehne, 2016, Scientific Reports.

Production of potent fully human polyclonal antibodies against Zaire Ebola virus in transchromosomal cattle

J. Dye, A. Herbert, A. Kuehne, 2015 .

CCR9A and CCR9B: Two Receptors for the Chemokine CCL25/TECK/Ckβ-15 That Differ in Their Sensitivities to Ligand

K. Peden, H. Golding, J. Farber, 2000, The Journal of Immunology.

Differ in Their Sensitivities to Ligand-15 That β Chemokine CCL 25 / TECK / Ck CCR 9 A and CCR 9 B : Two Receptors for the Hana Golding

K. Peden, H. Golding, J. Farber, 2000 .

Phorbol ester-induced down modulation of tailless CD4 receptors requires prior binding of gp120 and suggests a role for accessory molecules

C. Broder, J. Robinson, D. Dimitrov, 1995, Journal of virology.

Receptor activity modifying protein‐3 mediates the protumorigenic activity of lysyl oxidase‐like protein‐2

G. Neufeld, H. Golding, V. Brekhman, 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Statistical Approach To Estimate Vaccinia-Specific Neutralizing Antibody Titers Using a High-Throughput Assay

V. Pankratz, R. Kennedy, G. Poland, 2009, Clinical and Vaccine Immunology.

Titers Using a High-Throughput Assay Vaccinia-Specific Neutralizing Antibody Statistical Approach To Estimate

V. Pankratz, R. Kennedy, G. Poland, 2009 .

Characterization of a new subfamily of class I genes in the H-2 complex of the mouse

D. Singer, S. Rudikoff, H. Golding, 1988, Immunogenetics.

Human Herpesvirus 6 Infects Dendritic Cells and Suppresses Human Immunodeficiency Virus Type 1 Replication in Coinfected Cultures

H. Asada, A. Blauvelt, H. Golding, 1999, Journal of Virology.

Human herpesvirus 6 (HHV6) infects dendritic cells (DC) and suppresses HIV replication in co-infected cultures

H. Asada, A. Blauvelt, H. Golding, 1998 .

Patients with MS under daclizumab therapy mount normal immune responses to influenza vaccination

Hana Golding, Bibiana Bielekova, Andrew Blake, 2016, Neurology: Neuroimmunology & Neuroinflammation.

In vivo allogeneic effects: shift in the isotype profile of primary TI-2 responses in mice undergoing graft-vs-host reaction.

H. Golding, M. Rittenberg, 1982, Journal of immunology.

In vitro and in vivo allogeneic effects: differential modulation of B cell subpopulations.

H. Golding, M. Rittenberg, 1982, Journal of immunology.

Influenza vaccination reveals sex dimorphic imprints of prior mild COVID-19

W. Lau, R. Apps, J. Tsang, 2023, Nature.

Influenza vaccination and single cell multiomics reveal sex dimorphic immune imprints of prior mild COVID-19

W. Lau, R. Apps, J. Tsang, 2022, medRxiv.

Therapeutic potential of convalescent plasma and SARS-CoV-2 hyperimmune immunoglobulins against BQ.1, BQ.1.1 and XBB variants.

S. Khurana, H. Golding, L. Bellusci, 2023, The Journal of clinical investigation.

HIV-Selectest Enzyme Immunoassay and Rapid Test: Ability To Detect Seroconversion following HIV-1 Infection

J. Margolick, B. Haynes, F. Hecht, 2009, Journal of Clinical Microbiology.

Modeling a safer smallpox vaccination regimen, for human immunodeficiency virus type 1-infected patients, in immunocompromised macaques.

J. Berzofsky, B. Moss, D. Venzon, 2003, The Journal of infectious diseases.

Relationship among function, phenotype, and specificity in primary allospecific T cell populations: identification of phenotypically identical but functionally distinct primary T cell subsets that differ in their recognition of MHC class I and class II allodeterminants.

A. Singer, H. Golding, S. McCarthy, 1987, Journal of immunology.

Influenza A Virus Hemagglutinin Trimerization Completes Monomer Folding and Antigenicity

Javier G. Magadán, Gregory M. Frank, J. Yewdell, 2013, Journal of Virology.

FDA/NIH/WHO public workshop on immune correlates of protection against influenza A viruses in support of pandemic vaccine development, Bethesda, Maryland, US, December 10-11, 2007.

M. Eichelberger, K. Subbarao, H. Golding, 2008, Vaccine.

Harmonization of Zika neutralization assays by using the WHO International Standard for anti-Zika virus antibody

T. Pierson, I. Ushiro-Lumb, R. Tedder, 2019, npj Vaccines.

Subunit Recombinant Vaccine Protects against Monkeypox

D. Venzon, J. Héraud, M. Bray, 2006 .

against Monkeypox Subunit Recombinant Vaccine Protects

D. Venzon, J. Héraud, M. Bray, 2006 .

Application of Bioluminescence Imaging (BLI) to the Study of the Animal Models of Human Infectious Diseases

H. Golding, M. Zaitseva, 2014 .

AID Activity in B Cells Strongly Correlates with Polyclonal Antibody Affinity Maturation in-vivo Following Pandemic 2009-H1N1 Vaccination in Humans

B. Blomberg, D. Frasca, S. Khurana, 2012, PLoS pathogens.

Influenza Virus H1N1pdm09 Infections in the Young and Old: Evidence of Greater Antibody Diversity and Affinity for the Hemagglutinin Globular Head Domain (HA1 Domain) in the Elderly than in Young Adults and Children

S. Khurana, H. Golding, T. Ross, 2012, Journal of Virology.

Immune response following H1N1pdm09 vaccination: differences in antibody repertoire and avidity in young adults and elderly populations stratified by age and gender.

R. Karron, S. Khurana, H. Golding, 2012, The Journal of infectious diseases.

T cell–derived soluble glycoprotein GPIbα mediates PGE2 production in human monocytes activated with the vaccine adjuvant MDP

Rong-Fong Shen, Yukinori Endo, H. Golding, 2019, Science Signaling.

CCR5 N-terminal Region Plays a Critical Role in HIV-1 Inhibition by Toxoplasma gondii-derived Cyclophilin-18*

J. Andersen, A. Sher, C. Owman, 2005, Journal of Biological Chemistry.

Impaired B cell immunity in acute myeloid leukemia patients after chemotherapy

M. Goswami, C. Hourigan, B. Smith, 2017, Journal of Translational Medicine.

Generation of primary murine CTL specific for allogeneic and xenogeneic MHC determinants upon stimulation with murine L cells transfected with class I genes.

J. Bluestone, A. Singer, H. Golding, 1985, Journal of immunology.

Induction of IL-12 Secretion and Enhanced Surface Expression of B7.1/B7.2 and ICAM-1 in Human Monocytes Activated by the Vaccine Carrier Brucella Abortus: Correlation with in Vivo Generation of Cellular Immune Responses

B. Golding, H. Golding, M. Zaitseva, 1997 .

Mode of action of adjuvants: implications for vaccine safety and design.

S. Reed, P. Lambert, H. Golding, 2010, Biologicals : journal of the International Association of Biological Standardization.

Partial reconstitution of TNP-Ficoll responses and IgG3 expression in Xid mice undergoing graft-vs-host reaction.

H. Golding, M. Rittenberg, P. Foiles, 1982, Journal of immunology.

In vitro reversal of cellular unresponsiveness induced by levamisole.

B. Golding, H. Golding, H. Koornhof, 1976, Clinical and experimental immunology.

Initial stages of HIV-1 envelope glycoprotein-mediated cell fusion monitored by a new assay based on redistribution of fluorescent dyes.

D. Dimitrov, R. Blumenthal, H. Golding, 1991, AIDS research and human retroviruses.

Differences in PGE2 Production between Primary Human Monocytes and Differentiated Macrophages: Role of IL-1β and TRIF/IRF3

Yukinori Endo, H. Golding, M. Zaitseva, 2014, PloS one.

Antibody repertoire induced by SARS-CoV-2 spike protein immunogens

S. Khurana, H. Golding, Juanjie Tang, 2020, bioRxiv.

Mind the gap from research laboratory to clinic: Challenges and opportunities for next-generation assays in human diseases

D. O’Connor, S. Kleinstein, G. Tomaras, 2021, Vaccine.

Humans with chronic granulomatous disease maintain humoral immunologic memory despite low frequencies of circulating memory B cells.

T. Chun, A. Fauci, S. Khurana, 2012, Blood.

Monitoring of human immunological responses to vaccinia virus.

M. Carroll, H. Golding, I. Redchenko, 2004, Methods in molecular biology.

HIV peptide conjugated to heat-killed bacteria promotes antiviral responses in immunodeficient mice.

D. Scott, B. Golding, J. Inman, 1998, AIDS research and human retroviruses.

Cell fusion mediated by interaction of a hybrid CD4.CD8 molecule with the human immunodeficiency virus type 1 envelope glycoprotein does occur after a long lag time

D. Dimitrov, D. Littman, R. Blumenthal, 1993, Journal of virology.

Prolonged evolution of the memory B cell response induced by a replicating adenovirus-influenza H5 vaccine

Cinque S. Soto, Yicheng Guo, S. Migueles, 2019, Science Immunology.

Vaccine-Induced Anti-HA2 Antibodies Promote Virus Fusion and Enhance Influenza Virus Respiratory Disease

A. Vincent, P. Gauger, S. Khurana, 2013, Science Translational Medicine.

Bacterial HA1 Vaccine against Pandemic H5N1 Influenza Virus: Evidence of Oligomerization, Hemagglutination, and Cross-Protective Immunity in Ferrets

S. Khurana, J. Manischewitz, L. King, 2010, Journal of Virology.

Interferon γ and interleukin 6 modulate the susceptibility of macrophages to human immunodeficiency virus type 1 infection

J. Manischewitz, L. King, H. Golding, 2000 .

AS03-adjuvanted H5N1 vaccine promotes antibody diversity and affinity maturation, NAI titers, cross-clade H5N1 neutralization, but not H1N1 cross-subtype neutralization

R. Germain, N. Young, J. Tsang, 2018, npj Vaccines.

ICOS+PD-1+CXCR3+ T follicular helper cells contribute to the generation of high-avidity antibodies following influenza vaccination

H. Ueno, A. Palucka, A. Palucka, 2016, Scientific Reports.

Production of a novel antigen by conjugation of HIV-1 to Brucella abortus: studies of immunogenicity, isotype analysis, T-cell dependency, and syncytia inhibition.

B. Golding, J. Manischewitz, H. Golding, 1991, AIDS research and human retroviruses.

Toxoplasma gondii inhibits R5 HIV-1 replication in human lymphoid tissues ex vivo.

A. Sher, J. Grivel, L. Margolis, 2009, Microbes and infection.

Pharmacokinetics and Efficacy of Human Hyperimmune Intravenous Immunoglobulin Treatment of SARS-CoV-2 Infection in Adult Syrian Hamsters

B. Golding, S. Khurana, H. Golding, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Neutralization of SARS-CoV-2 Omicron after vaccination of patients with myelodysplastic syndromes or acute myeloid leukemia

P. Srivastava, S. Khurana, H. Golding, 2022, Blood.

Impaired B cell immunity in acute myeloid leukemia patients after chemotherapy

M. Goswami, C. Hourigan, B. Smith, 2017, Journal of Translational Medicine.

Comparative Evaluation of the Immune Responses and Protection Engendered by LC16m8 and Dryvax Smallpox Vaccines in a Mouse Model

J. Manischewitz, L. King, H. Golding, 2009, Clinical and Vaccine Immunology.

Decreased Serologic Response in Vaccinated Military Recruits during 2011 Correspond to Genetic Drift in Concurrent Circulating Pandemic A/H1N1 Viruses

Christopher D. Clagett, P. Blair, Angelia A. Eick-Cost, 2012, PloS one.

Production of leukocyte inhibitory factor (LIF) in Hodgkin's disease. Spontaneous production of an inhbiitor of normal lymphocyte transformation.

B. Golding, H. Golding, H. Koornhof, 1977, Clinical immunology and immunopathology.

Brucella abortus conjugated with a peptide derived from the V3 loop of human immunodeficiency virus (HIV) type 1 induces HIV-specific cytotoxic T-cell responses in normal and in CD4+ cell-depleted BALB/c mice

B. Golding, J. Inman, J. Manischewitz, 1996, Journal of virology.

Increased CXCR4-dependent HIV-1 Fusion in Activated T Cells: Role of CD4/CXCR4 Association

J. Manischewitz, H. Golding, M. Zaitseva, 2005, Retrovirology.

Coreceptor Competition for Association with CD4 May Change the Susceptibility of Human Cells to Infection with T-Tropic and Macrophagetropic Isolates of Human Immunodeficiency Virus Type 1

Hana Golding, Howard Mostowski, Hong Chen, 2000, Journal of Virology.

Heterovariant cross-reactive B-cell responses induced by the 2009 pandemic influenza virus A subtype H1N1 vaccine.

K. Subbarao, C. Dekker, S. Sasaki, 2013, The Journal of infectious diseases.

Mucosal immunity in mice immunized with HIV-1 peptide conjugated to Brucella abortus.

D. Scott, B. Golding, J. Inman, 2002, Vaccine.

A Simple Flow-Cytometric Method Measuring B Cell Surface Immunoglobulin Avidity Enables Characterization of Affinity Maturation to Influenza A Virus

Gregory M. Frank, J. Yewdell, J. Bennink, 2015, mBio.

Human lymphocytes can generate thymus-independent as well as thymus-dependent anti-hapten plaque-forming cell responses in vitro.

B. Golding, H. Golding, M. Rittenberg, 1981, Journal of immunology.

Differential human antibody repertoires following Zika infection and the implications for serodiagnostics and disease outcome

S. Khurana, H. Golding, G. Ruiz-Palacios, 2019, Nature Communications.

AS03-adjuvanted H5N1 vaccine promotes antibody diversity and affinity maturation, NAI titers, cross-clade H5N1 neutralization, but not H1N1 cross-subtype neutralization

R. Germain, N. Young, J. Tsang, 2018, npj Vaccines.

Chemically selected subclones of the CEM cell line demonstrate resistance to HIV-1 infection resulting from a selective loss of NF-kappa B DNA binding proteins.

V. Bours, J. Manischewitz, H. Golding, 1994, Journal of immunology.

Neutralization of HIV-1.

J. Bradac, H. Golding, P. Fast, 1994, AIDS research and human retroviruses.

Systemic and mucosal immune profiling in asymptomatic and symptomatic SARS-CoV-2–infected individuals reveal unlinked immune signatures

S. Khurana, H. Golding, Juanjie Tang, 2021, Science advances.

CBA/N X-linked defect delays expression of the Y-linked accelerated autoimmune disease in BXSB mice.

B. Golding, H. Golding, P. Foiles, 1983, Journal of immunology.

H3N2 Influenza Infection Elicits More Cross-Reactive and Less Clonally Expanded Anti-Hemagglutinin Antibodies Than Influenza Vaccination

T. Kepler, X. Chen, C. Woods, 2011, PloS one.

Dissection of Human Immunodeficiency Virus Type 1 Entry with Neutralizing Antibodies to gp41 Fusion Intermediates

S. Zolla-Pazner, M. Gorny, D. Dimitrov, 2002, Journal of Virology.

Cross-reactivity of rat, mouse, and human IgD.

H. Golding, M. Rittenberg, G. Leslie, 1979, Journal of immunology.

Reduced control of SARS-CoV-2 infection is associated with lower mucosal antibody responses in pregnant women

E. Klein, S. Klein, A. Pekosz, 2023, medRxiv.

Systemic and mucosal immunity in rhesus macaques immunized with HIV‐1 peptide and gp120 conjugated to Brucella abortus

S. Inoue, D. Scott, B. Golding, 2004, Journal of medical primatology.

Pause in immunosuppressive treatment results in improved immune response to SARS-CoV-2 vaccine in autoimmune patient: a case report

B. Golding, S. Khurana, H. Golding, 2021, Annals of the Rheumatic Diseases.

Protective antigenic sites identified in respiratory syncytial virus fusion protein reveals importance of p27 domain

S. Khurana, H. Golding, Juanjie Tang, 2021, EMBO molecular medicine.

Quantification of Humoral Immune Response to Influenza Vaccination in MDS

P. Srivastava, J. Manischewitz, L. King, 2019, Blood.

LFA-1 adhesion molecules are not involved in the early stages of HIV-1 env-mediated cell membrane fusion.

D. Dimitrov, R. Blumenthal, H. Golding, 1992, AIDS research and human retroviruses.

Reduced susceptibility to HIV-1 infection of ethyl-methanesulfonate-treated CEM subclones correlates with a blockade in their protein kinase C signaling pathway.

J. Manischewitz, H. Golding, J. Qian, 1992, Journal of Immunology.

Chemically induced CD4 mutants of a human T cell line. Evidence for dissociation between binding of HIV I envelope and susceptibility to HIV I infection and syncytia formation.

J. Hooley, J. Manischewitz, H. Golding, 1990, Journal of Immunology.

Increased association of glycoprotein 120-CD4 with HIV type 1 coreceptors in the presence of complex-enhanced anti-CD4 monoclonal antibodies.

C. Broder, D. Dimitrov, H. Golding, 1999, AIDS research and human retroviruses.

Global Analyses of Human Immune Variation Reveal Baseline Predictors of Postvaccination Responses

F. Marincola, Manikandan Narayanan, D. Chaussabel, 2014, Cell.

MF59 Adjuvant Enhances Diversity and Affinity of Antibody-Mediated Immune Response to Pandemic Influenza Vaccines

J. Yewdell, R. Rappuoli, S. Khurana, 2011, Science Translational Medicine.

Polyclonal antibody cocktails generated using DNA vaccine technology protect in murine models of orthopoxvirus disease

Senta M Kapnick, M. Mikolajczyk, H. Golding, 2011, Virology Journal.

Breadth of SARS-CoV-2 neutralization and protection induced by a nanoparticle vaccine

D. Weissman, Haiyan Chen, Laura L. Sutherland, 2022, Nature Communications.

Vaccines with MF59 Adjuvant Expand the Antibody Repertoire to Target Protective Sites of Pandemic Avian H5N1 Influenza Virus

R. Rappuoli, M. Rock, K. Edwards, 2010, Science Translational Medicine.

Light chain shifts during normal and abnormal murine b cell maturation. Abstr.

H. Golding, M. Rittenberg, P. Foiles, 1980 .

H3N2 Influenza Infection Elicits More Cross-Reactive and Less Clonally Expanded Anti-Hemagglutinin Antibodies Than Influenza Vaccination

T. Kepler, X. Chen, C. Woods, 2011, PloS one.